Literature DB >> 6196588

The carbohydrate antigenic determinant 19-9 (CA 19-9): a monoclonal antibody defined tumor marker.

B C DelVillano, V R Zurawski.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6196588

Source DB:  PubMed          Journal:  Lab Res Methods Biol Med        ISSN: 0160-8584


× No keyword cloud information.
  6 in total

1.  [CA 19-9 in the differential diagnosis of pancreatic lesions].

Authors:  S Stintzing; C Herold; E G Hahn; F Boxberger
Journal:  Internist (Berl)       Date:  2008-02       Impact factor: 0.743

2.  CA 125 and CA 19-9 in peritoneal, cyst and amniotic fluids.

Authors:  P Inaudi; L Pasqui; G C Torre; F M Severi; G Centini; W Gioffré; S Danero; N D'Antona
Journal:  Med Oncol Tumor Pharmacother       Date:  1988

3.  Prognostic value of CA 19.9 levels in colorectal cancer.

Authors:  X Filella; R Molina; J J Grau; J M Piqué; J C Garcia-Valdecasas; E Astudillo; A Biete; J M Bordas; A Novell; E Campo
Journal:  Ann Surg       Date:  1992-07       Impact factor: 12.969

4.  The clinical validity of circulating tumor-associated antigens CEA and CA 19-9 in primary diagnosis and follow-up of patients with gastrointestinal malignancies.

Authors:  H J Staab; T Brümmendorf; A Hornung; F A Anderer; G Kieninger
Journal:  Klin Wochenschr       Date:  1985-02-04

5.  Prognostic value of serum CA 19-9 levels in pancreatic adenocarcinoma.

Authors:  F Tian; H E Appert; J Myles; J M Howard
Journal:  Ann Surg       Date:  1992-04       Impact factor: 12.969

6.  External quality assessment of tumour marker analysis: state of the art and consequences for estimating diagnostic sensitivity and specificity.

Authors:  Hans Reinauer; William Graham Wood
Journal:  Ger Med Sci       Date:  2005-05-30
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.